Average Insider

Where insiders trade, we follow

$FEMY
Femasys Inc., a biomedical company, focuses on women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; FemCerv, a biopsy device for endocervical curettage; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. It also commercializes FemVue saline-air device in the United States, Europe, Canada, Japan, and internationally. The company offers its infertility products to obstetrics-gynecological physicians, related healthcare professionals, women's healthcare provider organizations, and reproductive endocrinologists. In addition, it provides non-surgical product technologies. Femasys Inc. was incorporated in 2004 and is based in Suwanee, Georgia.
Healthcare
Sector
Medical - Instruments & Supplies
Industry
Kathy Lee-Sepsick
CEO
69
Employees
$1.31
Current Price
$14.57M
Market Cap
52W Low$1.25
Current$1.310.3% above low, 99.7% below high
52W High$22.20

Insider Activity Statistics

Aggregated buying and selling activity by time period
PeriodTypeInsidersTransactionsValueSharesBuy/Sell Ratio
1 weekBuys00---
Sells00--
2 weeksBuys00---
Sells00--
1 monthBuys00---
Sells00--
2 monthsBuys00---
Sells00--
3 monthsBuys00---
Sells00--
See activity going back 12 months โ€” create a free account

Insider Transactions

Recent purchases and sales by company insiders
No transactions in the last 3 months. Sign up free to see 12 months of history.

Upcoming Earnings

Scheduled earnings reports
Nov 17, 2026
EPS
Estimated-$0.60
ActualN/A
Revenue
Estimated$619.50K
ActualN/A

Past Earnings

Historical earnings results
Nov 13, 2026
EPS
Estimated-$0.60
Actual-$0.53
Beat
Revenue
Estimated$619.50K
Actual$404.60K
Miss
1 more earnings records available โ€” create a free account to see 12 months of history
Version: v26.10.12